CFDE Data Portal | Search LUADT1

	Label	Description
	LUADT1 Gene (Entity type)	ENSG00000196634 - lung adenocarcinoma associated transcript 1
	GSE100148 EZH2 inhibition 4 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE178340 carfilzomib MM1.S 5 v 9 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE130715 budesonide muscle organ 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE147816 GSE147817 LSD1 inhibition McCoy 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 sulforaphane 11 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE133661 C19orf12 knockdown A-549 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 9 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE178340 carfilzomib MM1.S 5 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 9 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS

LUADT1

ENSG00000196634 - lung adenocarcinoma associated transcript 1

GSE100148 EZH2 inhibition 4 v 5 human dn

A Gene Set from LINCS

GSE178340 carfilzomib MM1.S 5 v 9 human dn

A Gene Set from LINCS

GSE130715 budesonide muscle organ 2 v 3 human up

A Gene Set from LINCS

GSE147816 GSE147817 LSD1 inhibition McCoy 0 v 1 human dn

A Gene Set from LINCS

GSE48812 sulforaphane 11 v 5 human dn

A Gene Set from LINCS

GSE133661 C19orf12 knockdown A-549 0 v 1 human dn

A Gene Set from LINCS

GSE100148 EZH2 inhibition 9 v 5 human dn

A Gene Set from LINCS

GSE178340 carfilzomib MM1.S 5 v 6 human dn

A Gene Set from LINCS

GSE100148 EZH2 inhibition 9 v 7 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.